Chronic Obstructive Pulmonary Disease (copd) - Drug Pipeline Analysis And Market Forecasts To 2016

Summary

Summary

The industry analysis specialist, has released a new report, Chronic Obstructive Pulmonary Disease (COPD) Drug Pipeline Analysis and Market Forecasts to 2016. The report is an essential source of information and analysis on the global COPD market, a key segment within the pharmaceutical and healthcare industry. This pharma report identifies the key trends shaping and driving the global COPD market. The report also provides insights on the prevalent competitive landscape and the companies expected to significantly alter the market landscape. Most importantly, the report provides valuable insights on the pipeline products within the global COPD sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

The scope of the report includes:

- Annualized global COPD market revenues data from 2001 to 2009, forecast for seven years to 2016.

- Geographies covered in this report are the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include phosphodiesterase IV (PDE4) inhibitors, long-acting beta2 agonists (LABA), long-acting muscarinic antagonists (LAMA), long-acting beta2 agonist, inhaled corticosteroid combinations and LABA and LAMA combinations.

- Analysis of the current and future market competition in the global COPD market. The key market players covered are GlaxoSmithKline, Novartis AG, Pfizer Inc, AstraZeneca, Forest Laboratories, Merck & Co, Boehringer Ingelheim and Sepracor Inc.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- The key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future COPD market.

For more information, please visit:

http://www.aarkstore.com/reports/Chronic-Obstructive-Pulmonary-Disease-COPD-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-37923.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by: Aarkstore Enterprise

POST COMMENT

Rome Complete Day Out Points: Places To Sleep, Feast, Fun, And Attractions The Disease Of Drug Addictions What are the Benefits of Winter Wedding Herblife? Boom Shacka Lacka. Fab 4 Shopping Tips to Create Healthy Meal Plans Where To Buy Stylish Spyder Winter Wear Antibacterial All Purpose Cleaners Starting Your Baby Off with a Healthy Diet Lyme Disease - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market When You Should Seek Medical Health Advice For Hair Thinning Looks do matter - enhance them with Denali body kits Bursting health myths Organic Bodybuilding Pursuing Swiftly Forms Muscle tissue